Etablissement Français du Sang;Université Grenoble Alpes;Centre Hospitalier Universitaire Grenoble
发明人:
申请号：
EP17305173.1
公开号：
EP3363460A1
申请日:
2017.02.16
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention is related to a live-attenuated strain of Pseudomonas for its use as a vaccine, and for use in a method for preventive immunizing and for treating Pseudomonas infection, in particular in patients suffering from cystic fibrosis. Preferably, the live-attenuated strain of Pseudomonas is furthermore treated to become 'killed but metabolically active'.
